Loading...
OTC Markets
Totals
Securities
12,299
Dollar Vol
$2.6B
Share Vol
5.4B
Trades
376,657

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

IMMG
Immage Biotherapeutics Corp.

Common Stock

Immage Biotherapeutics Corp.

10411 Motor City Dr.

Suite 750

Bethesda, MD 20817

(443) 961-1185

info@immagebio.com
Business Description
Immage Biotherapeutics is a biotechnology company developing cancer immunotherapy through the rapid and efficient development of cutting edge immunotherapy candidates. The company is in the process of developing novel key cancer immunotherapy candidates that can be licensed to the biotechnology and pharmaceutical industry, allowing them the opportunity to develop in vitro proven treatments.
Financial Reporting
Reporting Status
Dark: Alternative Reporting Standard
Audited Financials
Audited
Latest Report
CIK
0001564273
Fiscal Year End
8/31
Company Officers & Contacts
Anton Dormer
CSO

Mou Zhi Cong
CEO

Mahesh Narayanan
COO

Elton Norman
CFO

Dr. Daniel Achinko
EVP

Dr. William M. Brown, Ph.D, M.B.A.,
Advisory Director

Georgia M. Dunston
Advisory Director

Dr. Stephen Popielarski
Advisory Director

Dr. Tamaro Hudson
Advisory Director

Board of Directors
Anton Dormer
Chairman

Mou Zhi Cong
CEO

Mahesh Narayanan

Elton Norman

Other Company Insiders

Not available

Other Company Insiders are all persons or entities beneficially owning 10% or more of any class of the issuer's securities. Together, officers, directors and other company insiders comprise Company Insiders.
Service Providers
Accounting/Auditing Firm
MaloneBailey, LLP

10350 Richmond Avenue,

Suite 405

Houston, TX 77042

Profile Data
SIC - Industry Classification
2834 - Pharmaceutical preparations
Incorporation Information
NV, US, 2012
Employees
5 as of 03/31/2017
Shell
No
Products and Services

Not available

Company Facilities

Not available

Company Notes
12(k) Suspension for the period commencing at 9:30 a.m. on April 4, 2017 and terminating at 11:59 p.m. EDT on April 18, 2017.
Formerly=Epicure Charcoal Inc until 6-2015
Caveat Emptor Icon
This market serves broker-dealer pricing and investor best execution needs. Quotations in Expert Market securities are restricted from public viewing.
Expert Market
OTC Markets Group is unable to confirm this company is providing public disclosure to a regulator, an exchange, or OTC Markets Group.
Buyer Beware: OTC Markets Group has determined that there is a public interest concern associated with the company.
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.